Gion M - Search Results

1

Evaluation of cell-free DNA in urine as a marker for bladder cancer diagnosis.

Zancan M, Galdi F, Di Tonno F, Mazzariol C, Orlando C, Malentacchi F, Agostini M, Maran M, Del Bianco P, Fabricio AS, Murer B, Pianon C, Gion M. Zancan M, et al. Among authors: gion m. Int J Biol Markers. 2009 Jul-Sep;24(3):147-55. doi: 10.1177/172460080902400304. Int J Biol Markers. 2009. PMID: 19787625 Free article.

2

Clinical profile of a new monoclonal antibody-based immunoassay for tissue polypeptide antigen.

Correale M, Arnberg H, Blockx P, Bombardieri E, Castelli M, Encabo G, Gion M, Klapdor R, Martin M, Nilsson S, et al. Correale M, et al. Among authors: gion m. Int J Biol Markers. 1994 Oct-Dec;9(4):231-8. doi: 10.1177/172460089400900405. Int J Biol Markers. 1994. PMID: 7836801 Clinical Trial.

3

Relationship between cytosol TPS, TPA and cell proliferation.

Gion M, Mione R, Becciolini A, Balzi M, Correale M, Piffanelli A, Giovannini G, Saccani Jotti G, Fontanesi M. Gion M, et al. Int J Biol Markers. 1994 Apr-Jun;9(2):109-14. doi: 10.1177/172460089400900208. Int J Biol Markers. 1994. PMID: 7930761 Clinical Trial.

4

Third-generation PSA: ultrasensitive or ultraprecise assay?

Mione R, Barichello M, Sartorello P, Leon A, Barioli P, Gion M. Mione R, et al. Among authors: gion m. Int J Biol Markers. 1995 Oct-Dec;10(4):229-33. doi: 10.1177/172460089501000408. Int J Biol Markers. 1995. PMID: 8750651

5

Impact of steroid receptors, pS2 and cathepsin D on the outcome of N+ postmenopausal breast cancer patients treated with tamoxifen.

Dittadi R, Biganzoli E, Boracchi P, Salbe C, Mione R, Gatti C, Gion M. Dittadi R, et al. Among authors: gion m. Int J Biol Markers. 1998 Jan-Mar;13(1):30-41. Int J Biol Markers. 1998. PMID: 9681297

6

Prostate cancer probability after total PSA and percent free PSA determination.

Mione R, Barioli P, Barichello M, Zattoni F, Prayer-Galetti T, Plebani M, Aimo G, Terrone C, Manferrari F, Madeddu G, Caberlotto L, Fandella A, Pianon C, Vianello L, Gion M. Mione R, et al. Among authors: gion m. Int J Biol Markers. 1998 Apr-Jun;13(2):77-86. doi: 10.1177/172460089801300203. Int J Biol Markers. 1998. PMID: 9803355

7

Percent free prostate-specific antigen in assessing the probability of prostate cancer under optimal analytical conditions.

Gion M, Mione R, Barioli P, Barichello M, Zattoni F, Prayer-Galetti T, Plebani M, Aimo G, Terrone C, Manferrari F, Madeddu G, Caberlotto L, Fandella A, Pianon C, Vianello L. Gion M, et al. Clin Chem. 1998 Dec;44(12):2462-70. Clin Chem. 1998. PMID: 9836713 Clinical Trial.

8

How tumor markers are used in the routine follow-up of breast and colorectal cancer. A survey of 29 Italian hospitals.

Gion M, Barioli P, Ponti A, Torri V, Mione R, Dittadi R. Gion M, et al. Int J Biol Markers. 1998 Jul-Sep;13(3):124-38. Int J Biol Markers. 1998. PMID: 10079386

9

CA27.29: a valuable marker for breast cancer management. A confirmatory multicentric study on 603 cases.

Gion M, Mione R, Leon AE, Lüftner D, Molina R, Possinger K, Robertson JF. Gion M, et al. Eur J Cancer. 2001 Feb;37(3):355-63. doi: 10.1016/s0959-8049(00)00396-8. Eur J Cancer. 2001. PMID: 11239757

10

Validation of blood collection procedures for the determination of circulating vascular endothelial growth factor (VEGF) in different blood compartments.

Dittadi R, Meo S, Fabris F, Gasparini G, Contri D, Medici M, Gion M. Dittadi R, et al. Among authors: gion m. Int J Biol Markers. 2001 Apr-Jun;16(2):87-96. Int J Biol Markers. 2001. PMID: 11471901

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

244 results

Search Page